Longitudinally Extensive Transverse Myelitis: One Disease, Variable Outcomes-A Case Series

Shyam Chandrasekar1, Joseph John1, Amit Kumar Satapathy1

  • 1Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.

Insights

Longitudinal extensive transverse myelitis (LETM) is a rare spinal cord inflammation with varied symptoms and causes. Early immunomodulatory therapy may improve outcomes in children with LETM.

Area of Science:

  • Neurology
  • Pediatrics
  • Immunology

Background:

  • Longitudinal extensive transverse myelitis (LETM) is a rare, severe spinal cord inflammation.
  • LETM presents acutely with sensory, motor, and autonomic dysfunction, often with poor prognosis.
  • Pediatric LETM cases exhibit diverse clinical presentations and etiologies.

Purpose of the Study:

  • To present a case series of three children diagnosed with LETM.
  • To highlight the varied clinical manifestations and diagnostic challenges of pediatric LETM.
  • To discuss the role of immunomodulatory therapies in managing LETM.

Main Methods:

  • Case series analysis of three pediatric patients (ages 4-13) with LETM.
  • Clinical assessment, neurological examination, and contrast-enhanced MRI spine were performed.
  • Treatment involved pulsed dose methylprednisolone, intravenous immunoglobulin, and oral prednisolone.

Main Results:

  • Patients presented with diverse symptoms including vision loss, seizures, abdominal pain, urinary retention, constipation, and limb weakness.
  • Spinal MRI revealed long segment T2 hyperintensity in all cases, with some brain involvement.
  • Two of three children showed faster recovery with early immunomodulatory treatment.

Conclusions:

  • LETM in children has varied presentations and etiologies.
  • Testing for Aquaporin-4 IgG and anti-myelin oligodendrocyte glycoprotein antibodies is recommended.
  • Prompt and aggressive immunomodulatory therapy can facilitate recovery in pediatric LETM.